Mercurials have been shown to cause apoptosis in human T cells. The objective of this study was to evaluate and compare the relative susceptibility of resting versus activated T cells to methyl mercury chloride (MeHgCl)-induced cell death. Apoptosis was assessed by Hoechst 33258 and 7-AAD staining and annexin V binding. Our results show that activation of T cells by PHA, PMA, and ionomycin, or IL-2, reduces mercury-induced apoptosis by approximately 50%. We have previously shown that the underlying basis for these toxic effects involves perturbation of mitochondrial function leading to oxidative stress and the release of cytochrome c to the cytosol. Therefore, the ability of MeHgCl to alter the mitochondrial transmembrane potential (⌬⌿ m ) and to induce the generation of reactive oxygen species (ROS) was evaluated in activated T-cells. Both resting and activated cells treated with MeHgCl exhibited a decrease in ⌬⌿ m when compared to respective control cells. ROS production was elevated in resting cells following treatment with mercury; in contrast, fewer activated T cells exhibit increased levels of ROS in the presence of MeHgCl. Similarly, MeHgCl treatment resulted in the release of cytochrome c to the cytoplasm in non-activated T cells but failed to do so in the activated population. These results lead us to examine intracellular levels of bcl-2, a protein that has been shown to regulate apoptosis, presumably via its ability to associate with the mitochondrial membrane. Bcl-2 levels were found, in resting cells, to be low in the presence or absence of mercury. In comparison, activated T cells expressed elevated levels of bcl-2. The relationship between mercury-induced apoptosis in human T cells, mitochondrial dysfunction, and intracellular levels of bcl-2 are discussed.
Over the past decade, considerable concern has been expressed about the exposure of human populations to toxic substances such as mercury. Sources of mercury include contaminated water supplies, seafood, seeds, foodstuffs, and dental amalgam. Numerous studies have documented that acute exposure to high levels of mercury leads to nephrotoxicity and neurotoxicity (Ashour et al., 1993; Atchison and Hare, 1994; Clarkson, 1997; Harada, 1995) . More recently, there has been increasing interest in the effects of chronic exposure to low levels of mercurial compounds, especially with respect to their immunotoxic potential. Indeed, several investigators have demonstrated chromosomal aberrations in lymphocytes obtained from individuals exposed to mercury (De Flora et al., 1994; Franchi et al., 1994) . For instance, Langworth et al. (1993) demonstrated that workers occupationally exposed to mercury vapor exhibited diminished capacity to produce both TNF␣ and IL-1. Similarly, Silbergeld et al. (1998) and Kaiser (1998) have recently suggested that the high incidence of malaria among gold miners may be the result of exposure to mercury. Apart from these reports, most studies concerning the immunotoxic properties of mercuric compounds have been performed on animals. A number of investigations have demonstrated that mercurials are capable of immune activation leading to autoimmune disease, while others report that the same mercuric compounds inhibit rodent lymphocyte function and promote infection (Blakley et al., 1980; Dieter et al., 1983; Lawrence, 1981; Nakatsuru et al., 1985; Nordlind, 1983; Pelletier et al., 1987; Thuvander et al., 1996; Van der Meide et al., 1993; Wild et al., 1997) . Since different effects of mercurial exposure appear to be both species-and strain-specific, it is difficult to extrapolate observations made in animal systems to the human situation.
To address the concerns discussed above, we have initiated studies focused on characterizing the immunotoxic properties of mercuric compounds on human lymphoid cells and to determine the underlying basis for these effects. Findings to date indicate that both organic and inorganic mercurials kill human lymphocytes and monocytes; moreover, cell death is the result of the induction of apoptosis (Insug et al., 1997; Shenker et al., 1992 Shenker et al., , 1997 . Prior to cell death, there is a profound decrease in the adenine nucleotide energy charge ratio, altered phospholipid synthesis, and elevation in intracellular levels of Ca ϩϩ . More recently, we have demonstrated that cells exposed to either mercuric chloride (HgCl 2 ) or methyl mercuric chloride (MeHgCl) exhibit plasma membrane alterations reflected in translocation of phosphatidylserine to the outer leaflet and increased permeability to Hoechst stains. These events occur even though the cells are still capable of excluding vital stains (Insug et al., 1997; Shenker et al., 1997) . Furthermore, the cells exhibit morphological alterations, including DNA fragmentation among others, typically associated with apoptosis. Finally, we have recently shown that the mitochondrion is the target organelle and that altered mitochondrial function, in conjunction with depressed thiol levels, leads to oxidative stress.
In this study we address the issue of whether the metabolic status of human T cells influences their susceptibility to the apoptogenic effects of MeHgCl. Specifically, we report that activated T cells exhibit reduced sensitivity to the toxic effects of MeHgCl. Moreover, resistance is reflected in a reduction in permeability to Hoechst 33258, ROS generation, and the release of cytochrome c to the cytosol. Our findings also suggest that reduced susceptibility to the apoptotic effects of mercury is related to the intracellular level of the anti-apoptotic protein bcl-2.
MATERIALS AND METHODS
Cell isolation and culture. Peripheral blood mononuclear cells (PBMC) were isolated by Ficoll-Hypaque (Pharmacia Biotech, Uppsala, Sweden) gradient centrifugation of blood from healthy donors (21-40 years old). Blood mercury burden was measured by flameless atomic absorption spectrophotometry as previously reported (Shenker et al., 1992) and found to be below detectable levels. Replicate experiments employed different donors and no individual variation in the effective dose response to mercury was noted. Purified populations of human T cells were obtained by the E-rosette technique (Shenker et al., 1995) . Following rosetting, cells were centrifuged on a FicollHypaque and the sheep erythrocytes were lysed. When stained with anti-CD3 monoclonal antibody (Becton Dickinson Immunocytometry Systems; San Jose, CA), and analyzed by flow cytometry, this fraction contained Ͼ98% T cells. Lymphocyte cultures (1 ml) containing 10 6 cells (or as noted) were established in medium containing RPMI1640 (GIBCO; Grand Island, NY), antibiotics, and human AB serum (as indicated); cells were incubated for 24 h (or as noted) in medium alone (controls), or activated with: PHA (1 g/ml) (Sigma Chemical Co., St. Louis, MO), concanavalin A (Con A; 4 g/ml; Sigma Chemical Co.), PMA and ionomycin (IONO) (PMA, 0.01 g/ml; IONO, 0.4 g/ml; Sigma), IL-2 (200 U; Boehringer Mannheim, Indianapolis, IN), IL-4 (50 ng/ml; Sigma), or IL-1 (100 ng/ml; Sigma). After 24 h, varying amounts of methyl mercuric chloride (MeHgCl; ICN Pharmaceuticals, Irvine, CA) were added and the cells incubated for an additional 24 h (or as indicated).
Flow cytometric analysis of apoptosis. The fluorescent probes Hoechst 33258 (Sigma) and 7-amino-actinomycin (7-AAD; Sigma) were used to identify apoptotic T cells. T cells (10 6 cells/ml) were exposed to medium or MeHgCl for 16 h; the cells were then stained with Hoechst 33258 (1 g/ml) and 7-AAD (1 g/ml) as previously described . Hoechst fluorescence was excited at 310 nm (50 mW), and emission was detected with a 424/44 bandpass filter. Seven-AAD fluorescence was excited with a second laser at 488 nm (250 mW) and detected with a 680/30 bandpass filter. Cells undergoing apoptosis are defined as those exhibiting bright Hoechst 33258 fluorescence; T cells that also exhibit 7-AAD fluorescence are considered to be in the late stage of apoptosis and also undergoing secondary necrosis.
The translocation of phosphatidylserine to the outer leaflet of the plasma membrane was analyzed by measuring annexin V-FITC binding using a commercial kit (R & D Systems, Minneapolis, MN). Briefly, cells (10 cells/ml) were cultured for 4 h in the presence of medium or MeHgCl, washed in cold PBS, and then resuspended in binding buffer. After incubation with FITC conjugated annexin V and 7-AAD for 15 min, cells were analyzed by FACS for FITC fluorescence within 1 h of staining, as previously described .
Analysis of mitochondrial transmembrane potential (⌬⌿ m ) and ROS generation. T cells (10 6 cells/ml) were treated with medium or MeHgCl for 16 h. The ⌬⌿ m and generation of superoxide anion were measured using 40 nM 3,3Ј-dihexyloxacarbocyanine [DiOC 6 (3); Molecular Probes; Eugene, OR] and 2 M hydroethidine (Molecular Probes), respectively (Castedo et al., 1995; Insug et al., 1997) . Fluorescence was measured after staining the cells with the fluorochromes for 15 min at 37°C. The probes were excited with a laser at 488 nm (250 mW), and emission was monitored through a 530/30 nm bandpass filter for DiOC 6 (3) and 575/26 nm bandpass filter for ethidium; the latter is the fluorescent product of hydroethidine oxidation by superoxide anion (Insug et al., 1997) . Logarithmic amplification was used to detect the fluorescence; at least 10,000 cells were analyzed per sample for DNA fragmentation.
Analysis of T cells for cytochrome c and bcl-2 content by Western blot. T cells (2.5 ϫ 10 6 /ml) were cultured in the presence of medium or MeHgCl and harvested in buffer containing: 220 mM mannitol, 68 mM sucrose, 50 mM PIPES-KOH, pH 7.4, 50 mM KCl, 5 mM EGTA, 2 mM MgCl 2 , 1 mM DTT, 10 M cytochalasin B, 1 mM PMSF, and 10 g/ml each of leupeptin, chymostatin, antipain, and pepstatin. After 30 min on ice, cells were disrupted with a glass homogenizer as described by Kluck (1997a) . Following centrifugation at 14,000 ϫ g for 15 min, 30 g of cytosolic protein were fractionated by SDS-PAGE and analyzed by Western blot analysis using monoclonal antibody to cytochrome c (PharMingen, San Diego, CA). The blots were washed and treated with goat anti-mouse Ig antibody coupled to peroxidase (Southern Biotechnology AssocЈs., Inc., Birmingham, AL); the bound antibody was detected by chemiluminescence (DuPont NEN Research Products, Boston, MA). The relative amount of cytosolic cytochrome c was assessed by digital scanning densitometry (Molecular Dynamics, Sunnyvale, CA).
To assess bcl-2 protein content, cells were exposed to medium or MeHgCl and harvested in a lysing buffer containing 50 mM Tris, 150 mM NaCl, 0.5% NP-40, 0.0125% sodium meta vanadate, 0.2% sodium fluoride, 0.015% benzamide, and 0.0025% each of aprotinin, leupeptin, and trypsin inhibitor, and sonicated for 30 s. After centrifugation (670 ϫ g), 20 g of protein was fractionated by SDS-PAGE and analyzed by Western blot analysis, using monoclonal antibody to bcl-2 (Santa Cruz Biotechnology, Inc., CA) as described above.
Statistical analysis.
Results are reported as mean Ϯ SEM for at least 3 experiments; each experiment was performed in triplicate. FACS data represent a minimum of 3 experiments; at least 10,000 cells were analyzed for each sample.
RESULTS
The susceptibility of human T cells to the apoptogenic effects of MeHgCl was assessed following activation by both mitogens and cytokines. Initially, we evaluated mercury-induced apoptosis by multi-parameter flow cytometric analysis, employing the fluorescent probes Hoechst 33258 and 7-AAD. We have previously shown that this is a sensitive and reliable indicator of apoptosis ; furthermore, this technique is able to discriminate between apoptosis and necrosis. Figure 1 shows the effect of mitogenic stimulation on T-cell susceptibility to mercury-induced apoptosis. Both unstimulated ( Fig. 1D ) or PMA and ionomycin ( Fig. 1F ) and then treated with MeHgCl exhibit reduced susceptibility to the apoptotic effects of mercury. Under these conditions, MeHgCl kills a total of 21% of the PHA-activated cells and 20.0% of the PMA-and ionomycinactivated cells. Furthermore, altered susceptibility to mercury is reflected in an increase in the LD 30 value from 2.9 M in non-activated cells to 6.9 M in PHA-activated T cells, respectively (see Fig. 2 ). It should be noted that we observed only slight protection in similar experiments where Con A was employed to activate the T cells (data not shown).
Cytokine-activated T cells were also assessed for altered susceptibility to the cytotoxic effects of mercury (Fig. 3) . T cells were cultured in the presence of medium alone, IL-1, IL-2 or IL-4 and then treated with apoptogenic concentrations of MeHgCl. Control cultures (Fig. 3A) exhibit 13% apoptotic cells in the absence of mercury and in the presence of 5 M MeHgCl, 32% of the cells undergo apoptosis. Following activation with IL-2, 5.7% of the control cells exhibit bright Hoechst 33258 fluorescence (Fig. 3B) while 20% of these cells become apoptotic after mercury treatment (Fig. 3D) . Hence, IL-2 activation leads to resistance to MeHgCl, however, the protection is not as profound as that observed following PHA activation. We were unable to detect altered susceptibility to MeHgCl in T cells pre-treated with either IL-1 or IL-4 (data not shown).
Another feature of MeHgCl-induced T-cell apoptosis is a change in the lipid organization of the plasma membrane resulting in translocation of phosphatidylserine to the outer leaflet (Koopman et al., 1994; Martin et al., 1995) . In contrast to Hoechst 33258 fluorescence, which detects relatively late events in the apoptotic cascade, phosphatidylserine translocation represents an early (within 2 h) plasma membrane modification. Phosphatidylserine translocation was assessed by measuring the binding of annexin V-FITC to cells. As shown in Figure 4A We previously demonstrated that mitochondria represent the target organelle for mercury-induced apoptosis. Thus, mercury exposure leads to altered function, which is reflected in a decline in the mitochondrial transmembrane potential (⌬⌿ m ), ROS generation, intracellular acidification, and cytochrome c release. Therefore, we next conducted experiments to determine if activation could protect cells at the level of the mitochondria. We first assessed the ⌬⌿ m by using the fluorescent dye DiOC 6 (3) which is incorporated into mitochondria driven by the change in ⌬⌿ m (Shapiro, 1994) . As shown in Figure 5 , resting T cells exhibit bright DiOC 6 (3) fluorescence (mean (Figs. 5B and 5C ). In the absence of mercury, activated T cells exhibit bright DiOC 6 (3) fluorescence with mean channels of 405 (PHA) and 398 (IL-2). Both PHA (77%) and IL-2 (96%) activated T cells treated with mercury exhibit reduced DiOC 6 (3) fluorescence comparable to that observed in the non-activated cells; the mean channel fluorescence is 40 and 33, respectively.
Another feature of altered mitochondrial function in mercury-treated T cells is the generation of ROS. To assess ROS generation, we monitored the O 2 Ϫ• dependent conversion of dihydroethidine to the fluorescent product, ethidium. In the absence of mercury, 2-4% of either resting or activated cells generate detectable levels of O 2 Ϫ• (Fig. 6 ). After treatment with MeHgCl for 16 h, 52% of the resting T cells generate ROS [ Fig. 6A ; (Eth bright )]; this compares to 36 and 27% Eth bright T cells in the PHA [ Fig. 6B ) and IL-2 (Fig. 6C )-activated populations, respectively. Thus, in contrast to ⌬⌿ m , T cell activation protects mercury-treated lymphocytes from the subsequent production of ROS.
The release of cytochrome c from mitochondria into the cytosol is not only an indication of altered mitochondrial function, but has recently been recognized as an important feature of the apoptotic cascade (Kluck et al., 1997b; Liu et al., 1996; Reed, 1997; Yank et al., 1997) . We assessed and com- Fig. 1 legend) . Note that control cells (A, C) form a single discrete population with low Hoechst and 7-AAD fluorescence. In contrast, treated with MeHgCl, a second population of cells is seen that is apoptotic, as it exhibits an increase in Hoechst fluorescence and low 7-AAD staining (B, D). Cells that also have elevated 7-AAD fluorescence are probably in the late stages of apoptosis and also are undergoing secondary necrosis. The percentage of cells in each quadrant is presented in the boxes as: LL, lower left quadrant; UL, upper left quadrant; LR, lower right quadrant; UR, upper right quadrant. These results are representative of 3 experiments; at least 10,000 cells were analyzed. pared the ability of mercury to induce the release of cytochrome c from mitochondria of resting, versus activated T cells. Western blot analysis indicates that there is no detectable cytosolic cytochrome c in untreated resting cells (Fig. 7, lane  1) . Following treatment with 5 M MeHgCl, significant amounts of cytosolic cytochrome c are observed in the nonactivated population (Fig. 7, lane 2) . In contrast, PHA-activated T cells exhibit small, but detectable amounts of cytosolic cytochrome c (Fig. 7; lane 3) . Treatment of the PHA-activated T cells with MeHgCl did not result in an increase in cytochrome c translocation.
FIG. 4. Effect of MeHgCl on plasma membrane lipid organization in resting and activated T cells. Resting T cells (A) and PHA-activated cells (B)
were treated with mercury (solid line) or with medium alone (broken line) for 4 h. The cells were analyzed by flow cytometry following staining with annexin V-FITC and 7-aminoactinomycin; analytical gates were set so that these data include only 7-aminoactinomycin-negative (viable) cells In order to determine the underlying basis for the protection observed in activated T cells, we analyzed the relative levels of the anti-apoptotic protein, bcl-2. The proto-oncogene product has been shown, not only to block apoptosis, but probably to act at the level of mitochondrial membranes. As shown in Figure 8 , resting T cells contain low levels of bcl-2; exposure to MeHgCl has minimal effects on the bcl-2 content of these cells. However, stimulation of T cells by PHA or IL-2 results in a 7-and 3-fold increase, respectively. Treatment of the activated cells with MeHgCl results in a 45-50% decline in bcl-2. It should be noted, however, that the bcl-2 levels of activated cells never fell below those observed in the resting T cells. Thus, it appears that T-cell susceptibility to the apoptotic effects of MeHgCl may be linked to the intracellular content of the bcl-2 protein. 1 and 2) or PHA (lanes 3 and 4) for 24 h. The cells were then treated with 5 M MeHgCl for 4 h (lanes 2 and 4) or medium alone (lanes 1 and 3) . The cells were then disrupted and the cytosol fraction was collected, fractionated by SDS-PAGE, and analyzed for cytochrome c content by Western blot. The relative amounts of cytochrome c were determined by scanning densitometry; values were 6.9 (lane 1, resting cells without mercury), 672 (lane 2, resting cells with mercury), 121 (lane 3, activated cells without mercury), and 53 (lane 4, activated cells with mercury). Note, a 95-fold increase in cytosolic cytochrome c was observed in mercurytreated resting cells; in contrast no increase in cytosolic cytochrome c was noted in the mercury-treated activated T cells. Results are representative of 3 experiments.
FIG. 8.
Bcl-2 expression in resting, versus activated T cells. T cells were incubated in the presence of medium, PHA, or IL-2. Twenty-four h later the cells were exposed to medium alone (-) or to 5 M MeHgCl (ϩ); the cells were then lysed, fractionated by SDS-PAGE, and analyzed for bcl-2 levels by Western blot. The relative amounts of bcl-2 were determined by scanning densitometry. Note, bcl-2 levels were elevated in all activated cells, regardless of whether or not they were subsequently treated with MeHgCl. The data are representative of 4 experiments.
DISCUSSION
It is becoming increasingly evident that environmental intoxicants such as mercury are capable of acting as immunotoxicants as well (Pollard and Hultman, 1997) . In this regard, our recent studies clearly demonstrate that mercurials are potent apoptogens with the capacity to induce human lymphocyte and monocyte death. Exposure of human lymphoid cells to both organic (methyl, phenyl and ethyl) and inorganic mercuric chloride results in molecular, biochemical and morphologic changes that are indicative of apoptosis. Our studies, to date, have been conducted with freshly isolated human lymphoid cells that exhibit minimal metabolic activity. The major goal of this investigation was to determine if the state of cell activation influences the ability of MeHgCl to cause human T cells to undergo apoptosis. It is clear from our investigation that lymphocyte susceptibility to the toxic effects of mercury is indeed dependent upon the metabolic state of the cell. Our findings indicate that activated T cells exhibit reduced susceptibility to mercury-induced apoptosis and provide further support for the notion that mitochondria represent the target organelle for mercury-dependent cell death.
Initially, we employed the fluorescent probes, Hoechst 33258 and 7-AAD, to identify apoptotic cells. In comparison to resting T cells, mercury treatment of mitogen-activated cells resulted in approximately 50% fewer apoptotic cells. Thus, prior incubation of T cells with mitogens such as PHA or PMA and ionomycin resulted in activation induced protection to the apoptotic effects of MeHgCl. Furthermore, prior exposure to IL-2 led to similar protection whereas treatment with other cytokines, such as IL-1 and IL-4, were unable to protect cells. Other aspects of apoptosis were also evaluated; these include DNA fragmentation and the binding of annexin V-FITC to phosphatidylserine, which translocates from the inner to the outer leaflet of the plasma membrane (Koopman et al., 1994; Martin et al., 1995; Vermes et al., 1995) . DNA fragmentation represents a late event in the apoptotic process, whereas phosphatidylserine translocation is observed within 2 h after mercury treatment. Activation of T cells by either PHA or IL-2 prior to treatment with mercury lead to a reduction in the number of cells exhibiting both DNA fragmentation (data not shown) and annexin V binding. Hence, activation-induced protection was observed in both mitogen and cytokine (IL-2) activated T cells; moreover, reduced susceptibility to mercuryinduced cell death was reflected in both early and late events associated with the apoptotic cascade. It is interesting to note that other investigators have also observed that lymphocyte activation can block apoptosis. For instance, Xie et al., (1997) reported that IL-2 treatment was effective in preventing dexamethasone-induced T-cell death; protection was attributed to altered NF-B activity. Similarly, Teague and co-workers (1997) observed that IL-6 prevented T-cell apoptosis by blocking the down-regulation of bcl-2.
Our previous studies provide strong evidence that mercuryinduced apoptosis involves perturbation of at least 2 systems: cytosolic thiol redox and mitochondrial energy metabolism leading to oxidative stress. It was logical, therefore, to propose that protection against the immunotoxic effects of MeHgCl might be linked to the enhanced ability of activated T cells to generate GSH and to control the intracellular oxidative state. We were unable, however, to attribute protection to alterations in the thiol redox status of the cell. For instance, significant increases in intracellular GSH content of T cells was not detected within 24 h of mitogenic activation (data not shown). Furthermore, treatment of activated T cells with BSO (to reduce intracellular GSH) failed to restore mercury sensitivity to levels observed in the nonstimulated population. Therefore, we turned our attention to mitochondria, where perturbations in ion distribution and pH across the inner membrane can result in pore formation and a decrease in ⌬⌿ m . This in turn contributes to the induction of a complex state, described as the mitochondrial permeability transition (MPT) (Meisenholder et al., 1996) . Recently, considerable attention has been directed toward the development of the MPT, especially with regard to the induction of apoptosis (Castedo et al., 1995; Kroemer et al., 1997; Marchetti et al., 1996) . Indeed, our own studies demonstrate that one of the earliest events in lymphocytes treated with MeHgCl is development of the MPT. This is characterized by a decrease in the ⌬⌿ m and a decline in the intracellular pH, followed by the generation of ROS. Experiments were conducted to determine if cell activation results in protection at the level of either the ⌬⌿ m and/or generation of ROS. Interestingly, activated T cells were not protected from the MeHgCl dependent decrease in the ⌬⌿ m ; both resting and activated T cells exhibited a similar decline in ⌬⌿ m following exposure to mercury. PHA-activated lymphocytes were also evaluated for ROS generation by monitoring the O 2 Ϫ• dependent conversion of dihydroethidium to the fluorescent product, ethidium. In contrast to the resting T cells, fewer activated T cells generate ROS, following exposure to mercury.
One consequence of the MPT and mitochondrial dysfunction is the release of cytochrome c to the cytosol. Presence of cytochrome c in the cytosol has been linked to proteolytic processing and activity of Apaf-1 and Apaf-3 of caspase 3, a key mediator of the apoptotic process (Golstein, 1997; Kluck et al., 1997b; Zou et al., 1997) . Furthermore, we have recently shown that one of the early events triggered by MeHgCl in resting T cells is the efflux of cytochrome c from mitochondria. It was, therefore, significant that we failed to detect MeHgCldependent cytochrome c release in activated T cells. Thus it appears that activation-induced protection is not reflected in all aspects of mitochondrial function. Mitochondria of activated T cells subsequently treated with MeHgCl exhibit a decline in ⌬⌿ m , but did not generate ROS or release cytochrome c. It is tempting to speculate that, while the decline in ⌬⌿ m and the induction of the MPT may be important to the apoptotic cascade, the key events that ultimately contribute to cell death appear to be more closely linked to the release of cytochrome c, and the uncoupling of oxidative respiration leading to the generation of ROS.
Finally, in order to understand the mechanism by which cell activation results in protection, we turned our attention to bcl-2. Bcl-2 has been identified as a key regulator of apoptosis, and overexpression of this protein has been shown to block cell death (Kiefer et al., 1995; Marchetti et al., 1996; Petit et al., 1996; Reed, 1994; Shimizu et al., 1995) . Of particular importance to our studies, this protein appears to act at the level of the mitochondria where it binds to the external surface of the membrane. How bcl-2 acts is controversial; evidence exists for a mode of action whereby it blocks the formation of permeability pores and the development of the MPT as well as the subsequent release of cytochrome c (Caron-Leslie et al., 1994; Decaudin et al., 1997; Hirsch et al., 1997; Jacobson and Raff, 1995; Kharbanda et al., 1997; Kim et al., 1997) . Other studies indicate that bcl-2 acts as an antioxidant and protects the cell from damage caused by oxidative stress (Hockenbery et al., 1993) . Our results indicate that the intracellular levels of bcl-2 inversely correlate with the level of T cell susceptibility to mercury. Resting cells show minimal levels of bcl-2 and are very sensitive to the apoptogenic effects of MeHgCl. In contrast, activated T cells (both mitogen and IL-2) exhibit elevated levels of bcl-2; these cells exhibit reduced susceptibility to mercury-induced cell death. More importantly, mercury treatment failed to perturb 2 important aspects of mitochondrial function in the activated cell population: cytochrome c release and ROS generation. These studies also provide insight into the mechanism by which the anti-apoptotic protein, bcl-2, may act to prevent apoptosis. Collectively, our data suggest that, at least for mercury induced apoptosis, bcl-2 prevents cytochrome c release and not the formation of pores leading to the development of the MPT.
In conclusion, our findings clearly demonstrate that the immunotoxic properties of mercury are dependent, in part, upon the metabolic state of the cell. Thus, activated human T cells exhibit a phenomenon that we refer to as activationinduced protection; this is characterized as an increased tolerance to mercury, and possibly other apoptotic stimuli as well. More importantly, activation-induced protection provides important insight into the mechanism of toxicity exerted in the highly susceptible resting T cell population. Hence, our data provide further support that altered mitochondrial function represents a key event in the mercury-induced apoptotic cascade. Finally, this study provides further evidence that the immune system represents a potential target for mercuric compounds and that exposure to mercurials may result in insidious health effects associated with depressed immune function.
